Lung Health Services For Medical Specialties
-
Manufactured by Newcells Biotech Limitedbased in UNITED KINGDOM
In vitro assessment of Fibroblast-to-Myofibroblast transition (FMT). Newcells offers a fast and reliable FMT assay service to evaluate the efficacy of anti-fibrotic compounds using high-content imaging. This customisable, high-throughput assay is well suited to compound screening for small molecules targeting lung fibrosis. Normal repair processes are defective in the fibrotic lung. Repetitive ...
-
Manufactured by Alfa Chemistrybased in USA
Ifosfamide has been effectively employed in the treatment of multiple cancers, including testicular cancer, soft tissue sarcoma, osteosarcoma, bladder cancer, small cell lung cancer, non-Hodgkin lymphoma, Hodgkin lymphoma, epithelial ovarian cancer, cervical carcinoma and germ cell carcinoma of the ovary[1]. Among all these cancers, the Food and Drug Administration (FDA) has approved ifosfamide ...
-
Manufactured by Galera Therapeutics, Inc.based in USA
Harnessing the Anticancer Power of Hydrogen Peroxide: As cancer cells are more susceptible than normal cells to increased levels of hydrogen peroxide, we believe the conversion of radiation-generated superoxide to hydrogen peroxide by our selective dismutase mimetics can improve outcomes for patients who receive radiation ...
-
Distributed by SSEM Mthembu Medical (Pty) Ltd.based in SOUTH AFRICA
The company provides full installation, followed by comprehensive application support, giving its customers and users peace of mind. This includes the provision of clinical and training expertise through consultation, installation and on-site training. The cycle of support is maintained with the continuous upgrading and extension of equipment and ...
-
based in CANADA
Gene fusions are the result of other genomic events, such as translocation, interstitial deletion, or chromosomal inversion. Gene fusions are known to be driver mutations in many different tumors and more recently, have emerged as therapeutic targets. While relatively rare, for example ALK rearrangements have been reported as occurring in only 3–8% of non-small lung cell cases, the ...
-
Manufactured by ResMetrix Medical Ltdbased in ISRAEL
Resmetrix has developed a novel wearable respiratory monitoring system, that accurately monitors the respiratory pattern of respiratory disease patients (COVID-19, COPD, Asthma) and alert to the patient smartphone, and the medical team, when early signs of respiratory deterioration ...
-
Manufactured by Alfa Chemistrybased in USA
MRTX0902 is a potent SOS1 inhibitor which can be used for the therapeutic intervention of KRAS-driven (Kirsten rat sarcoma virus driven) cancers. Rat sarcoma (RAS) is the most frequently mutated oncogene in human cancer, with KRAS being the most commonly mutated RAS isoform. Overall, KRAS accounts for 85% of RAS mutations observed in human cancers and is present in 35% of lung adenocarcinomas ...
-
based in UNITED KINGDOM
EarlyCDT is a simple blood test that detects the elevated presence of autoantibodies generated by the body's immune system as a natural defence against cancer cells. EarlyCDT Lung is the world’s most thoroughly validated blood test for the detection of lung cancer and requires only a small volume of blood which can be taken in the community setting as well as a doctor’s surgery. Shown ...
-
Manufactured by Alfa Chemistrybased in USA
PF-06821497 is a potent EZH2 Inhibitor which can be used for the treatment of relapsed/refractory SCLC (small cell lung cancer), castration resistant prostate cancer, and follicular lymphoma. Alfa Chemistry offers high quality of PF-06821497 which can be a potent EZH2 Inhibitor for the treatment of relapsed/refractory SCLC (small cell lung cancer), castration resistant prostate cancer, and ...
-
Manufactured by Lungpacer Medical Inc.based in CANADA
Mechanical ventilation (MV) although life-saving, can also be harmful: MV and sedation cause the disused diaphragm muscle to atrophy rapidly and profoundly (ventilator induced diaphragm dysfunction; VIDD*)Positive-pressure ventilation often damages the lungs (ventilator induced lung injury; VILI) and may lead to ventilatorassociated pneumonia (VAP)MV requires intubation and depending on the ...
-
Manufactured by Applied Nanodetectors Limitedbased in UNITED KINGDOM
The diagnosis of asthma is currently limited, and are based on a mixture of clinical history, physical examination and lung function. To date, there are no accurate objective tests either to con?rm the diagnosis or to discriminate between different types of asthma. It has been estimated that more than 30% of people being diagnosed and treated for asthma may have no clear evidence of ...
-
by Strados Labsbased in USA
Beyond Cough Count: RESP Cough Trial Solution (CTS) optimizes chronic cough trials to better capture lung sound biomarkers. RESP allows clinical endpoints for coughs to be captured and show positive results. A portion of these positive results revolve around being able to differentiate between voluntary coughs vs. involuntary coughs to determining if the drug is working as planned. RESP makes ...
-
Manufactured by Mesothelioma + Asbestos Awareness Centerbased in USA
There is no cure for mesothelioma, but clinical trials and experimental treatments offer hope for the future. In the never-ending effort to eradicate cancer, there are medical and scientific researchers constantly looking for new ways to attack this deadly disease. Many of the commonly used methods of treating cancer today were once experimental, and the hope is that new, even more effective ...
-
by Advancellsbased in INDIA
Amyotrophic Lateral Sclerosis, most commonly called as the Lou Gehrig’s disease or motor neuron disease is a type of a progressive neurological illness that manifests as gradual weakening and atrophy of muscles. The progression of the disease can go up to as many as two to five years but in very rare cases a person can live up to seven years with 100% fatal outcome. Conventional ALS/MND ...
-
Manufactured by Kura Oncology, Inc.based in USA
Kura Oncology’s clinical trial programs represent the next step toward our goal of realizing the full potential of precision medicine. Our investigational trials are studying innovative therapeutic candidates with the potential to help patients with certain cancers live better, longer lives. ...
-
based in CANADA
Find It focuses on gene mutations that can be addressed by current FDA-approved therapies. Find It is more than an assay: it’s a complete solution. Canexia Health partners leverage our expert end-to-end support and proprietary technology as well as a focused panel that identifies therapeutic targets for patients, acquired drug resistance mutations, and mutations with prognostic and ...
-
based in CANADA
While tissue samples are the standard for cancer molecular profiling, tissue can often be challenging to obtain. Surgical biopsy may be risky or impossible, the biopsy procedure may have resulted in insufficient or exhausted tissue, or the sample acquired resulted in poor quality DNA. Whatever the reason, plasma assays can provide a less invasive alternative or complement to tissue assays. Plasma ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you